Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 30 June, 2004 and appeared in  Issue 214

Issue 214 Item 15 Hypoxia Acutely Induces Glucose Intolerance

Results of a study in healthy men suggest a causative role for hypoxia in acutely increasing glucose intolerance. Elevated release of epinephrine is one factor mediating this effect.
Advertisement
"Our results suggest that the presence of hypoxic diseases should be evaluated as a possible pathogenic factor in patients suffering from metabolic disorders such as type 2 diabetes and metabolic syndrome," German investigators write in the June 1st American Journal of Respiratory and Critical Care Medicine.

Several studies have shown a close tie between hypoxia and the emergence of glucose intolerance, Dr. Kerstin M. Oltmanns and colleagues from the University of Luebeck in Germany explain in the paper, but "experimental evidence of a causative role for hypoxia in this metabolic dysfunction is surprisingly lacking."

In a double-blind, within-subject crossover study, they tested the effects of hypoxia versus normoxia on glucose tolerance by decreasing oxygen saturation to 75% under conditions of a euglycemic clamp and monitoring the rate of dextrose infusion needed to maintain stable blood glucose levels.

They observed a significant decrease in glucose infusion rate (p < 0.01) over a period of 150 minutes after the onset of hypoxia in conjunction with an increase in plasma epinephrine (p < 0.01), heart rate (p < 0.01) and symptoms of anxiety (p < 0.05).

Of note, glucose intolerance was "closely comparable between hypoxic and hypoglycemic conditions (p < 0.9) despite clear differences in stress hormonal responses," Dr. Oltmanns and colleagues report.

The authors caution that while "providing evidence of a causative role for hypoxia in acutely elevating glucose intolerance, it remains to be carefully considered to what extent our findings after acute experimental short-term hypoxia can be generalized to the typical pathologic conditions in which frequent hypoxic episodes are encountered over long periods." Am J Respir Crit Care Med 2004;169:1231-1237.

===========================
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 30 June, 2004 and appeared in  Issue 214

Past five issues: Diabetes Clinical Mastery Series Issue 141 | Issue 681 | Diabetes Clinical Mastery Series Issue 140 | Issue 680 | Diabetes Clinical Mastery Series Issue 139 |

 
Diabetes In Control Advertisers
 
Cast Your Vote
If the FDA relaxes prescribing restrictions on Avandia, will you recommend it?

Navigate Diabetes In Control
Search Articles On Diabetes In Control